Search research articles
Contact Us
Filters
Showing results (131-140 of 393) with videos related to
Page
of 40
Sort By:
Hepatology Communications
|
January 6, 2026
Low serum pseudocholinesterase levels are associated with mortality in patients with hepatocellular carcinoma
Karina Sato-Espinoza, Marie-Lise Chrysostome, Robert A Vierkant, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
January 24, 2012
Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations
Scott M Thompson, Matthew R Callstrom, Bruce Knudsen, et al.
Cardiovascular and Interventional Radiology
|
January 24, 2014
Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study
Scott M Thompson, Matthew R Callstrom, Kim A Butters, et al.
Cells
|
March 11, 2023
The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth
Kishor Pant, Seth Richard, Estanislao Peixoto, et al.
Mayo Clinic Proceedings
|
May 12, 2007
Treatment options for hepatobiliary and pancreatic cancer
Steven R Alberts, Gregory J Gores, George P Kim, et al.
JNCI Cancer Spectrum
|
May 5, 2023
Opportunities to address gaps in early detection and improve outcomes of liver cancer
Brian McMahon, Chari Cohen, Robert S Brown, et al.
Hepatology Communications
|
May 19, 2023
Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, et al.
Abdominal Imaging
|
May 9, 2015
Biphenotypic hepatic tumors: imaging findings and review of literature
Michael L Wells, Sudhakar K Venkatesh, Vishal S Chandan, et al.
Radiology
|
July 24, 2019
Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in Small-Animal Model
Danielle E Jondal, Scott M Thompson, Kim A Butters, et al.
Targeted Oncology
|
December 13, 2016
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
Joleen M Hubbard, Michelle R Mahoney, William S Loui, et al.
Page
of 40
Search research articles
Search
Showing results (131-140 of 393) with videos related to
Sort By:
Page
of 40
Hepatology Communications
|
January 6, 2026
Low serum pseudocholinesterase levels are associated with mortality in patients with hepatocellular carcinoma
Karina Sato-Espinoza, Marie-Lise Chrysostome, Robert A Vierkant, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
January 24, 2012
Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations
Scott M Thompson, Matthew R Callstrom, Bruce Knudsen, et al.
Cardiovascular and Interventional Radiology
|
January 24, 2014
Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study
Scott M Thompson, Matthew R Callstrom, Kim A Butters, et al.
Cells
|
March 11, 2023
The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth
Kishor Pant, Seth Richard, Estanislao Peixoto, et al.
Mayo Clinic Proceedings
|
May 12, 2007
Treatment options for hepatobiliary and pancreatic cancer
Steven R Alberts, Gregory J Gores, George P Kim, et al.
JNCI Cancer Spectrum
|
May 5, 2023
Opportunities to address gaps in early detection and improve outcomes of liver cancer
Brian McMahon, Chari Cohen, Robert S Brown, et al.
Hepatology Communications
|
May 19, 2023
Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, et al.
Abdominal Imaging
|
May 9, 2015
Biphenotypic hepatic tumors: imaging findings and review of literature
Michael L Wells, Sudhakar K Venkatesh, Vishal S Chandan, et al.
Radiology
|
July 24, 2019
Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in Small-Animal Model
Danielle E Jondal, Scott M Thompson, Kim A Butters, et al.
Targeted Oncology
|
December 13, 2016
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
Joleen M Hubbard, Michelle R Mahoney, William S Loui, et al.
Page
of 40